Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - KEMPHARM, INC | kmph20161231_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - KEMPHARM, INC | ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - KEMPHARM, INC | ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - KEMPHARM, INC | ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - KEMPHARM, INC | ex31-1.htm |
| EX-10.31 - EXHIBIT 10.31 - KEMPHARM, INC | ex10-31.htm |
| EX-10.30 - EXHIBIT 10.30 - KEMPHARM, INC | ex10-30.htm |
| EX-10.29 - EXHIBIT 10.29 - KEMPHARM, INC | ex10-29.htm |
| EX-10.28 - EXHIBIT 10.28 - KEMPHARM, INC | ex10-28.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
|
1. |
Registration Statement (Form S-3 No. 333-213926) of KemPharm, Inc. |
|
2. |
Registration Statement (Form S-8 No. 333-210369) pertaining to the 2014 Equity Incentive Plan of KemPharm, Inc., and |
|
3. |
Registration Statement (Form S-8 No. 333-203703) pertaining to the Incentive Stock Plan, as amended, and the 2014 Equity Incentive Plan of KemPharm, Inc. |
of our report dated March 10, 2017, with respect to the financial statements of KemPharm, Inc. included in this Annual Report (Form 10-K) of KemPharm, Inc. for the year ended December 31, 2016.
/s/ Ernst & Young LLP
Tampa, Florida
March 10, 2017